YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus

NCT01836172 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Complication

Interventions

DRUG: YJP-14

Sponsor

Han Wha Pharma Co., Ltd.